Immune Design (IMDZ) Tops Q1 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Cowen Starts Immune Design (IMDZ) at Outperform
May 15, 2015 7:04 AM EDTCowen initiated coverage on Immune Design (NASDAQ: IMDZ) with an Outperform rating.
For an analyst ratings summary and ratings history on Immune Design click here. For more ratings news on Immune Design click here.
Shares of Immune Design closed at $21.29 yesterday.
... More


